FormWeb • DAPAGLIFLOZIN

North Mississippi Medical Center

Pharmacy Home Formulary Request Form P&T Approved Substitutions

Search by class Show Therapeutic Classes

Add Formweb to your mobile device

MISSISSIPPI POISON CONTROL CENTER 1-800-222-1222 -- EMERGENCY CONTACT FOR NERVE AGENT/ORGANOPHOSPHATE POISONING 1-800-222-MEMA (6362)

North Mississippi Medical Center

Pharmacy Home Formulary Request Form P&T Approved Substitutions

Search results for:

DAPAGLIFLOZIN

DAPAGLIFLOZIN

Brand names: FARXIGA

Form	Strength
TABLET	10 mg

VIEW MORE Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors
CLASS

Comments:

Approved May 2023 with restriction to the management of Heart Failure in the inpatient setting. Farxiga is not authorized to be used for the inpatient management of diabetes mellitus.

Last updated: Jun. 9, 2023

MISSISSIPPI POISON CONTROL CENTER 1-800-222-1222 -- EMERGENCY CONTACT FOR NERVE AGENT/ORGANOPHOSPHATE POISONING 1-800-222-MEMA (6362)
For NMMC Use Only.
Some links may not be viewed without INTRANET access.